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INTRODUCTION
Studies of immune mechanisms have focused on the effector 
functions of immune responses to pathogens or the immuno-
pathogenesis of autoimmune diseases. The discovery of CD4
+
Foxp3
+ regulatory T cells (Treg), which suppress antigen (Ag)-
specific immune effector cells, made negative immune regula-
tion a focus of work to characterize the pathogenesis of autoim-
munologic and allergic inflammatory diseases.
B cells that have ability to terminally differentiate into antibody 
(Ab)-secreting plasma cells, are generally considered to posi-
tively regulate immune responses by producing Ag-specific Abs 
and helping to induce optimal CD4
+ T cell activation.
1,2 B cells 
can also serve as antigen-presenting cells (APCs).
3 B cell-specif-
ic expression of co-stimulatory molecules, such as CD80, CD86, 
and OX40L, is also important for optimal T cell activation.
4,5
Evidence supporting B cell negative regulatory function has 
accumulated over the past 30 years. B cells and specific subsets 
thereof can negatively regulate immune responses in mice.
6-10 
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The absence, or loss, of these regulatory B cells exacerbates dis-
ease symptoms in allergic (including contact hypersensitivity 
and anaphylaxis), and autoimmune (such as experimental au-
toimmune encephalomyelitis, chronic colitis, collagen induced 
arthritis) diseases, and in lupus-like models of autoimmuni-
ty.
11-19 Moreover, B cells regulate immunological or allergic in-
flammation and T cell-mediated autoimmunity through the 
production of IL-10.
12-14,16-20 With these background, recent ad-
vances in knowledge of regulatory B cells and their clinical and 
immunological significance in allergy are described in this re-
view.
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B cells are generally considered to positively regulate immune responses by producing antigen-specific antibodies. B cells are classified into classi-
cal CD5
- conventional B cells and CD5
+ B1 cells. The latter produce multi-specific autoantibodies and are thought to be involved in autoimmune dis-
eases. However, evidence supporting a B cell negative regulatory function has accumulated over the past 30 years. Multiple reports have suggested 
that absence, or loss, of regulatory B cells exacerbates symptoms of both allergic (including contact hypersensitivity and anaphylaxis) and autoim-
mune (such as experimental autoimmune encephalomyelitis, chronic colitis, and collagen-induced arthritis) diseases, and in lupus-like models of au-
toimmunity. Regulatory B cells are characterized by production of the negative regulatory cytokines, IL-10 and TGF-β. IL-10-producing B cells were the 
first regulatory B cells to be recognized and were termed ‘B10’ cells. IL-10-producing regulatory B cells are of the CD19
+CD5
+IgM
hiIgD
loCD1d
hi type. Re-
cently, a TGF-β-producing regulatory B cell subset, Br3, has been shown to be related to immune tolerance in food allergies. Moreover, forkhead box 
P3 (Foxp3)-expressing B cells have also been identified in humans and may act as regulatory B cells (Bregs). The functional image of regulatory B 
cells is similar to that of regulatory T cells. Because of the proliferative and apoptotic responses of Br1 and Br3 cells in immune tolerance in non-IgE-
mediated food allergy, reciprocal roles and counter-regulatory mechanisms of Br1 and Br3 responses are also suspected. Additionally, different roles 
for regulatory B and T cells at different time points during initiation and progression of autoimmune disease are described.
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THE CD5
+ B1 AND CD5
- CONVENTIONAL B2 CELL 
SUBCLASS
Ly-1/CD5 is a 68 kDa glycoprotein that was originally thought 
to mark the helper subset of T cells.
21 It was shown to be present 
not only on all T cells, but also on a subset of B cells. In 1983, 
Hayakwawa et al.
22 originally distinguished a subset of mouse B 
cells that bear the pan-T cell glycoprotein Ly-1 (CD5). Evidence 
of the existence of a CD5-bearing B cell subset in humans was 
reported in 1986.
23 T cell markers were subsequently shown to 
be shared by B cells in some patients with chronic lymphocytic 
leukemia.
24 CD5, the human counterpart of the Ly-1 molecule 
in the mouse, is detectable, but is weakly expressed only on a 
minute fraction of circulating B cells.
25
Thereafter, CD5 expression served as a useful marker for a 
functionally distinct population of B cells that has attracted con-
siderable interest from investigators of both the murine and hu-
man immune systems.
21 B cells are classified according to CD5 
expression as CD5
+ B1 cells and CD5
- conventional B2 cells. B1 
cells emerge early in development, are abundant in the perito-
neal and pleural cavities, and are defined by their surface mark-
er expression pattern as B220
lo, IgM
hi, IgD
+, CD9
+, CD43
+, and 
CD23
lo. B2 cells are defined phenotypically as B220
hi, IgM
hi/lo, 
IgD
+, CD9
-, CD43
-, and CD23
hi. B1 cells are long-lived, self-re-
newing cells that produce polyreactive IgM, known as “natural 
antibodies,” and do not undergo extensive somatic hypermuta-
tion. The human B1 cell repertoire includes two distinct subsets: 
B1a cells, which develop from progenitors in the fetal splanch-
nic district, namely the omentum, and are maintained in adult 
life by virtue of their self-replenishing nature, and B1b cells, pro-
genitors of which can be found in the splanchnic district and, 
perhaps, adult bone marrow. B2 cells, which arise in the fetal 
liver and are continuously replenished in adult life by progeni-
tors in the bone marrow, are capable of generating hypermu-
tated antibodies, and play a central role in conventional adap-
tive humoral immune responses. Immature B2 cells develop in 
the bone marrow and migrate to the spleen, and are then called 
transitional B cells.
26
B1 cells play a major role in autoimmunity and constitute the 
physiological equivalent of the neoplastic forms in various lym-
phoproliferative disorders, such as chronic lymphocytic leuke-
mia (CLL), which are often associated with the production of 
monoclonal antibodies to self antigens. Human B1a (CD5
+ B) 
and B1b (CD5
- CD45RA
lo B) cells are responsible for the pro-
duction of natural (polyreactive and monoreactive) antibodies 
in the fetus, neonate, and adult, and can give rise to autoanti-
bodies producing cells characteristic of several autoimmune 
disease states. However, non-classical B1 cell functions are crit-
ical in the manifestation of several autoimmune diseases. Inde-
pendent of autoantibody production, B cells are essential for 
disease initiation or progression, either through APC function 
or the secretion of proinflammatory cytokines.
27
REGULATORY B CELLS
IL-10-producing regulatory B cells
Regulatory B cells, a ‘‘new’’ B cell population that suppresses 
immune responses, have been highlighted recently, in contrast 
to normal B cells, which function to augment immune respons-
es. The term ‘regulatory B cells’ to designate B cells with inhibi-
tory properties, was used for the first time by Mizoguchi and 
Bhan.
13,28 B cell deficiency in T cell receptor (TCR) α-deficient 
mice, which spontaneously develop colitis, results in an earlier 
onset of disease and exacerbated intestinal inflammation. Also, 
a suppressive function for IL-10-producing B cells (Br1 or B10) 
in collagen-induced arthritis (CIA) was reported.
14 Overall, these 
data suggest that regulatory B cells are key regulators of many 
disease states due to their production of IL-10.
Over the past decade, B cell negative regulation has been 
demonstrated in mouse autoimmunity models.
8,16,29 A pheno-
typically unique (CD1d
hiCD5
+CD19
hi) negative regulatory B cell 
subset in the spleens of naïve wild-type mice has been identi-
fied.
17 This regulatory B cell subset is Ag-specific and signifi-
cantly influences T cell activation and inflammatory responses 
through IL-10 production.
17,30 The IL-10-producing CD1d
hiCD5
+
CD19
hi regulatory subset designated ‘B10’ by Tedder and col-
leagues is responsible for most IL-10 production.
30
IL-10 is multi-potent in immune modulation, exerting anti-in-
flammatory and suppressive effects on most hematopoietic 
cells.
9 IL-10 is involved in not only inhibition of Th1 polariza-
tion but also prevents Th2 responses. Pro-inflammatory cyto-
kine production by monocytes and macrophages is suppressed 
by IL-10.
31 IL-10 expression in the mucosal environment is also 
critical for the generation of immunological tolerance.
32 Although 
IL-10 generally plays immunosuppressive roles, it also has 
pleiotropic and immunostimulatory activities. IL-10 released in 
local microenvironments is more critical for cell-to-cell interac-
tions than systemic IL-10.
B10 cell phenotype
Many groups have identified IL-10-producing regulatory B 
cells, but only a few studies have attributed these characteristics 
to specific B cell subpopulations.
9 IL-10-producing B10 cells are 
relatively rare within the spleen. Splenic IL-10
+ cells expressed a 
CD21
hiCD23
+IgM
hi CD1d
hiCD93
int phenotype, which is similar 
to the T2-marginal zone (MZ) precursor cell phenotype. The 
B10 cell phenotype is unique, but subsets thereof are pheno-
typically diverse. The categorization of B10 cells as CD1d
hiCD5
+ 
has been useful in defining the novel character of these B cells 
and for analyzing their distributions.
16 CD1d is expressed on a 
wide variety of cell types, including constitutive expression by 
most B cells.
33 In the mouse spleen, CD1d expression is higher 
on B cells of both the CD21
hiIgM
hiIgD
loCD24
intCD23
-CD43
- MZ 
and the CD21
hiIgM
hiIgD
hiCD23
+ T2 B cell subsets.
33
Concerning CD19 expression by IL-10-producing regulatory Noh et al.
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B cells, although Br1 has been reported in the CD19
hi pheno-
type group, most reports place it in the CD19
lo subpopulations.
34 
Further studies are needed to explain this discrepancy.
B10 cell development
Regulatory B cells have been characterized as having B1a, MZ, 
and T2-MZ precursor B cell origins. B10 cells are derived from 
B10 progenitor (B10pro) cells that may not fit into any precon-
ceived subset.
35 Neonatal mouse spleen B cells are IL-10-com-
petent CD1d
loCD5
+ B10pro cells. Prolonged stimulation induc-
es the CD1d
hiCD5
+ B cell subset to mature.
9 Anti-CD40 mAb and 
LPS induce maturation of B10 and B10pro cells.
B10 cell regulation of inflammation and autoimmunity is Ag-
specific.
17,30 Furthermore, B10 cell development is significantly 
influenced by B cell Ag receptor (BCR), because B10 cell num-
bers are reduced by approximately 90% in transgenic mice with 
a fixed BCR.
30 B10 cell frequency and numbers are also de-
creased by 70-80% in mice lacking CD19, which enhances 
transmembrane and BCR signaling and humoral immunity. 
CD40L dramatically enhanced the numbers of CD1d
hiCD5
+ B 
cells and IL-10-producing B cells.
16 BCR diversity and CD19-
generated signals are critical for normal B10 cell development 
and/or peripheral expansion, while enhanced B cell signaling 
significantly enhances B10 cell generation.
Despite the requirement for BCR expression during B10 cell 
development, B cell stimulation with mitogenic anti-IgM Ab 
does not induce cytoplasmic IL-10 expression.
30 BCR-generat-
ed signals inhibit the abilities of LPS and anti-CD40 mAb to in-
duce cytoplasmic IL-10 production. B10 development appears 
to be T cell-independent. Major histocompatibility complex 
(MHC) class I and class II molecules and CD1d expression are 
not required for B10 cell development.
30
B10 cell tissue distribution
B10 and B10pro cells, which secrete IL-10 after stimulation 
with CD40 agonistic antibody for 48 hours), are found in many 
tissues. B10 and B10pro cells have been identified in blood, 
bone marrow, lymph node, spleen, and the peritoneal cavity of 
adult mice.
9,16,17,30 B10 and B10pro cells normally represent about 
1-2 and 7-9% of adult mouse splenic B cells, respectively. B10 
cells (2-3% of CD19
+ B cells) and B10pro cells (5-6% of CD19
+ B 
cells) are also present in adult mouse bone marrow. The perito-
neal cavity may be a major B10 cell source, with up to 10% of B 
cells producing IL-10. Strikingly, 30-35% of peritoneal cavity B 
cells are B10pro cells, while peripheral blood and lymph nodes 
contain few, if any, B10 cells but 3-8% of the total B cell popula-
tion are B10pro cells.
9,17 Thus, B10 cells may be located predom-
inantly within the spleen and peritoneal cavity.
ADVANCES IN REGULATORY B CELLS AND THEIR 
NOMENCLATURE: IL-10-PRODUCING B CELLS, TGF-β-
PRODUCING REGULATORY B CELLS AND FOXP3
+ 
REGULATORY B CELLS
CD1d
hiCD5
+ B cells are responsible for most IL-10 production 
by B cells.
16 IL-10-producing B cells have been regarded as reg-
ulatory B cells and this specific subset of regulatory B cells has 
been termed “B10 cells.” Another regulatory B cell subset that 
produces transforming growth factor-β (TGF-β) after stimula-
tion with LPS has been also identified.
36 TGF-β is produced by 
both CD5
+ and CD5
- B cells from autoimmune-prone NZB 
mice,
37 and is also expressed by normal human B cells.
38
TGF-β-producing B cells are regarded as another regulatory 
type. These cells play essential roles in the induction of toler-
ance to non-IgE mediated food allergy in atopic dermatitis.
38 In 
a recent study, Foxp3-expressing B cells were identified within 
CD19
+CD5
+ B cells and were proposed to be regulatory B cells 
(Breg), comparable to Treg.
39
T and B cells are functionally classified into effector and nega-
tive regulatory cells. The latter type that produce negative regu-
latory/suppressive cytokines, such as TGF-β and IL-10, or ex-
press the transcription factor, Foxp3, are categorized as regula-
tory T and B cells (Fig. 1). The components of the regulatory B 
cell system are similar to those of regulatory T cells, including 
Type I IL-10- producing regulatory T cells (Tr1), Type III TGF-β-
producing helper T cells (Th3), and Treg. TGF-β induces apop-
tosis in CD5
+ B cells,
37 and IL-10 enhances the proliferation of 
CD5
+ cells in an autocrine manner.
40 Reciprocal effects of IL-10 
from Br1 and TGF-β from Br3 are shown in Fig. 2. Also, IL-10 
from Tr1 cells and TGF-β from Th3 cells have the same effect on 
Fig. 1. Regulatory B and T cells. Tr1, Th3, and regulatory T (Treg) cells produce 
IL-10 and/or TGF-β, and express Foxp3. B cells also produce IL-10, TGF-β, and 
Foxp3; these are termed Br1, Br3, and regulatory B cells (Breg). The B cell sys-
tem thus seems to be a mirror image of the T cell system.Regulatory B Cells in Allergy
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regulatory B cells.
Given recent advances in our understanding of the complexi-
ty of regulatory B cells, a systemic nomenclature is necessary. 
Lee and Noh named regulatory B cells systematically. First, 
considering the classification and nomenclature of CD5
+ B1 and 
CD5
- B2 cells, B10 cells may be another subset in addition to B1 
and B2 cells. The composition of regulatory B cells is similar to 
that of regulatory T cells. IL-10-producing regulatory B cells are 
termed ‘Br1,’ similar to Type I IL-10-producing regulatory ‘Tr1’ 
T cells. The nomenclature of Br1 cells (i.e., IL-10-producing reg-
ulatory B cells) should be made more reasonable.
41 Second, 
TGF-β-producing B cells are termed ‘Br3,’ like ‘Th3’ T cells. Third, 
recently, CD19
+CD5
+Foxp3
+ B cells, Foxp3-expressing regulato-
ry B cells, are designated Breg, similar to ‘Treg,’ CD4
+Foxp3
+ T 
cells.
39 Finally, the functional structure of regulatory B cells may 
be similar to that of regulatory T cells.
APOPTOTIC CHARACTERISTICS OF BR1 (B10) CELLS
Regulatory B cells are more highly apoptotic than T cells in 
human food allergies and atopic dermatitis. Br1 cells are more 
highly apoptotic than Tr1 cells;
41 furthermore, Br3
38 and Breg 
cells
39 are more apoptotic than either Th3 or Treg cells.
Recently, counter-regulation of immune responses has been 
suggested as a mechanism that prevents excessive immune re-
actions, and the apoptotic activity of regulatory B cells may be 
one counter-regulatory mechanism.
38,39,41 The physiological 
characteristics of regulatory B cells, including those relating to 
apoptosis, differ from those of regulatory T cells.
Th2.52 cells (i.e., CD5
+, B cell lines) are used for the study of 
the effects of cytokines on apoptosis of regulatory B cells. IFN-γ-
induced marked NO production through expression of the in-
ducible type of NO synthase (iNOS) and cell death.
42 IFN-γ-
induced NO production and cell death were inhibited by IL-4.
43 
Chronic lymphocytic leukemia (CLL) is a leukemic disease of 
CD5
+ B cells. IL-10 enhanced the survival of B-CLL cells in a 
dose-dependent manner by inhibiting apoptotic cell death,
40 
and acts as an autocrine growth factor for B-CLL cells. Recom-
binant IL-6 is also important for growth,
44 and protect CLL cells 
from apoptosis. TGF-β negatively regulates chronic lymphocyt-
ic leukemia,
45 and exhibits an antiproliferative effect on B-CLL 
cells in an autocrine manner.
46 TGF-β not only stimulates B cell 
apoptosis, but also induces apoptosis in CD5
+ B cells.
35
REGULATORY B CELLS IN ALLERGIC DISEASES
Contact hypersensitivity
Contact hypersensitivity is considered a prototypic Th1 cell-
mediated inflammatory reaction in which B cells are not in-
volved in antigen presentation and, therefore, have no or at 
most a very limited role in augmenting inflammation. The con-
tact hypersensitivity response is exacerbated in CD19-deficient 
mice.
47 CD19 expression is also critical in the regulatory B cell 
subset, and CD19 loss results in a defect in regulatory B cells. 
The splenic B cell subset which produces IL-10 displays a 
CD1d
hiCD5
+phenotype. IL-10-deficient mice also possess CD-
1d
hiCD5
+ B cells, although adoptive transfer of IL-10-deficient 
CD1d
hiCD5
+ B cells does not ameliorate contact hypersensitivi-
ty responses, suggesting that this suppression is IL-10-depen-
dent.
B1 cells in the peritoneal cavity are a rich source of IL-10, and 
suppress contact hypersensitivity, particularly in the late phase.
48 
CD22-deficient mice showed delayed recovery from contact 
hypersensitivity reactions compared with wild-type mice. Adop-
tive transfer of wild-type peritoneal B1 cells, but not IL-10-defi-
cient peritoneal B1 cells, reverses the prolonged hypersensitivi-
ty reactions of CD22- and CD19-deficient mice. Simultaneous 
injection of anti-IL-10 receptor antibody inhibits these phe-
nomena. Two distinct regulatory B cell subsets cooperatively 
inhibit contact hypersensitivity responses. Splenic CD1d
hiCD5
+ 
B cells have a crucial role in suppressing the acute exacerbating 
phase of contact hypersensitivity, while peritoneal B1a cells like-
ly suppress the late remission phase, although their role appears 
less significant than that of splenic B10 cells. The role of B1 cells 
in contact hypersensitivity remains controversial. Tsuji et al.
49 
reported a promoting, rather than inhibitory, role for peritoneal 
B1 cells in contact hypersensitivity. While B1 cells do indeed 
play a protective role in contact hypersensitivity,
50 it is possible 
that peritoneal B1 cells have both promoting and suppressive 
Fig. 2. Reciprocal roles of IL-10 from Br1 and TGF-β from Br3 cells on Br1 and 
Br3 cells. Br1 and Br3 cells belong to the CD5
+ B cell subset. Growth of CD5
+ B 
cells is stimulated by IL-10 in an autocrine manner, while TGF-β induces their 
apoptosis. IL-10 produced by Tr1 cells and TGF-β by Th3 cells have the same ef-
fects on CD5
+ B cells.Noh et al.
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roles.
Asthma and airway hyper-responsiveness
Allergic asthma is a chronic inflammatory disease of the air-
ways associated with airway hyper responsiveness (AHR) to in-
haled allergens and dysregulated type 2 immunity.
51 Dysregu-
lated type 2 immunity in allergic asthma is characterized by an 
expansion of CD4
+ Th-cell populations, with increased produc-
tion of Th2 cytokines (IL-4, IL-5, IL-13), elevated total and aller-
gen-specific IgE, eosinophilia, and airway inflammation. IL-10-
producing B cells have been shown to downregulate inflamma-
tion in airway hyper-responsiveness.
48 Also, regulatory B cells 
were reported to be involved in the pathogenesis of delayed-
type hypersensitivity via mediation of both early T cell recruit-
ment
52 and airway hyper-reactivity in non-atopic asthma.
53 In 
another report, regulatory B cells were protective against aller-
gic airway inflammation.
54
Despite the fact that helminth-infected individuals display the 
characteristic type 2 responses seen in patients with allergy, 
helminths have evolved multiple mechanisms to regulate in-
flammatory responses in the infected host.
55-58 Interest has fo-
cused on helminth induction of CD4
+ T cells that produce the 
regulatory cytokines TGF-β and IL-10. Treg cells, including thy-
mus-selected naturally occurring CD4
+CD25
+FoxP3
+ Treg cells 
and inducible IL-10-secreting Treg type 1 cells (Tr1), are involved 
in modulation of allergic asthma.
59 Infection with Schistosoma 
mansoni worms plays a role in suppression of allergen-induced 
AHR experimental murine models of allergic disease.
48 S. man-
soni-mediated protection from allergic airway inflammation was 
dependent on induction of both IL-10 and B cells.
IL-10-producing B cells suppress allergic inflammation.
60 
CD19
+IL-10
+CD1d
hiCD5
+CD21
hiCD23
+ IgD
+ IgM
hi Breg cells re-
verse allergic airway inflammation. Breg cell function is medi-
ated by IL-10 and dependent on the expression of CD1d. Breg 
cells suppress airway inflammation by inducing the recruitment 
of natural Treg (CD4
+CD25
+FoxP3
+) cells to the lungs in a TGF-
β-independent manner, with these Treg cells mediating the 
suppression of lung inflammation.
Anaphylaxis
A major role for IL-10-producing B cells has been described in 
the downregulation of inflammation in anaphylaxis.
60 S. man-
soni worms increased numbers of IL-10-producing B cells, and 
transfer of these cells protected recipient mice against experi-
mentally-induced anaphylaxis. Infection with S. mansoni worms 
plays a role in suppression of anaphylaxis and transfer of these 
cells protected recipient mice against experimentally-induced 
anaphylaxis. S. mansoni-mediated protection from anaphylaxis 
was dependent on induction of both IL-10 and B cells.
Non-IgE mediated food allergy of atopic dermatitis
The clinical significance of regulatory B cells, including Br1 and 
Br3, in non-IgE mediated food allergy and atopic dermatitis has 
been described. Atopic dermatitis is a chronic relapsing allergic 
dermatitis and food allergy plays an important role in atopic 
dermatitis.
61 An imbalance in the Th1/Th2 ratio is known to be 
important in the development of atopic dermatitis.
62 Food aller-
gies are classified as IgE-mediated, non-IgE-mediated, or mixed-
type.
63 Late eczematous reactions of the skin have been found 
to be diagnostic of non-IgE-mediated food allergy and almost 
identical to those in atopic dermatitis.
64 Due to a lack of avail-
able laboratory diagnostic tests, non-IgE-mediated food allergy 
has been underdiagnosed and undertreated.
65
Recently, the clinical significance of regulatory B cells in non-
IgE-mediated food allergy has been investigated. Br1 cells pro-
liferate in response to casein stimulation in milk-tolerant sub-
jects,
41 but not in milk allergy patients. Br3 cells also showed 
similar responses in non-IgE-mediated food allergy and prolif-
erated in response to allergen stimulation in milk-tolerant sub-
jects (Fig. 3).
38 Br1 and Br3 cells are critical for induction of im-
mune tolerance in non-IgE-mediated food allergy related to 
atopic dermatitis, while Treg responses have not been reported 
to be decisive in the development of either allergy or immune 
tolerance.
REGULATORY B CELLS IN HUMANS
Most studies concerning human B-cell production of IL-10 
have provided contradictory data, making the identification of 
regulatory B cells problematic. Human tonsil B cells secrete only 
low levels of IL-10 following BCR or CD40 ligation. While addi-
Fig. 3. Proliferative and simultaneous apoptotic responses of Br1 and Br3 cells 
to casein in milk-tolerant subjects. IL-10-producing Br1 and TGF-β-producing 
Br3 cells proliferate while simultaneously showing apoptotic changes. IL-10 
may stimulate proliferation of Br1 and Br3 cells, while TGF-β may induce their 
apoptosis.Regulatory B Cells in Allergy
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tion of exogenous IL-4 to cultures diminishes CD40-induced 
secretion of IL-10, addition of the Staphylococcus aureus Cow-
an I (SAC) polyclonal mitogen significantly increases IL-10 se-
cretion.
9 Epstein–Barr virus (EBV) infection of purified tonsil B 
cells induces high levels of IL-10. Neutralization of endogenous 
IL-10 does not alter the growth of CD40-activated B cells, but 
does inhibit their IgM, IgG, and IgA secretion. IL-10 may also 
synergize with IL-6 to sustain differentiation of CD40-activated 
B cells.
In contrast to mice, the main source of IL-10 in humans may 
not be CD5
+ B cells. CD5
+ B cells represent 40-60% of B cells in 
the human fetal spleen.
66 CD5
+ B cells are also present at high 
percentages in cord blood (~7%), while <2% of these cells ex-
hibit cytoplasmic IL-10 staining. However, after 24 hours stimu-
lation with PMA, 23% of cord blood CD5
+ B cells produced IL-
10.
67 Nonetheless, human cord blood CD5
+ B cells secrete only 
low levels of IL-10 following BCR or CD40 ligation.
68
Blair et al.
69 demonstrated that human CD19
+CD24
hiCD38
hi B 
cells exhibit regulatory activity. After CD40 stimulation, CD19
+
CD24
hiCD38
hi B cells suppressed the differentiation of Th1 cells, 
partially via the provision of IL-10, but not TGF-β, and their 
suppressive capacity was reversed by addition of CD80 and 
CD86 mAb. CD19
+CD24
hiCD38
hi B cells isolated from the pe-
ripheral blood of systemic lupus erythematosus (SLE) patients 
were refractory to CD40 stimulation, produced less IL-10, and 
lacked the suppressive capacity of their healthy counterparts. 
In contrast to murine regulatory B cells, the suppressive activity 
of human regulatory B cells is only partially dependent on IL-
10. Regulatory B cells also exist in humans; however, their sur-
face phenotype remains controversial.
Regulatory B cells and immune tolerance for allergy
Respiratory exposure to allergen induces development of al-
lergen-specific CD4
+ T cell tolerance that effectively protects 
against development of allergic-sensitization and T(h)2-biased 
immunity.
70 CD4
+Foxp3
+CD25
+ regulatory T cells play a domi-
nant role in immune tolerance and modulate immune reactions 
by secreting immunomodulatory cytokines, particularly TGF-β.
71 
Similarly, TGF β-producing Br3, and TGF-β-producing Th3, cells 
seem to be involved in immune tolerance, including allergy tol-
erance.
38 The presence of Foxp3
+ regulatory B cells (Bregs) has 
recently been reported
39 and are expected to have a negative 
regulatory role.
CELLULAR AND CYTOKINE NETWORK OF REGULATORY B 
CELLS IN ALLERGY AND TOLERANCE
Autocrine growth and counter-regulation of regulatory B cells 
in immune tolerance of food allergy
IL-10 produced by Br1 is involved in the autocrine growth of 
CD5
+ B1 cells, including Br1 and Br3,
40 while TGF-β, produced 
by Br3 cells, induces apoptosis of CD5
+ B cells.
38 During a toler-
ant reaction to allergen in non-IgE-mediated food allergy relat-
ed to atopic dermatitis, Br1 and Br3 proliferate in response to 
allergen stimulation.
38,40 Interestingly, Br1 and Br3 cells are not 
only highly apoptotic, compared with regulatory IL-10 (Tr1) 
and TGF-β (Th3)-producing T cells, but also show increased 
proliferation simultaneously with increasing apoptotic Br1 and 
Br3 cells in response to casein stimulation in milk-tolerant sub-
jects. The proliferatory and counter-regulatory roles of IL-10 
and TGF-β, respectively, may indicate the immunologic mecha-
nisms of the effects of Br1 and Br3 cells in tolerance reactions 
(Fig. 4). Further functional studies may be needed to elucidate 
precisely the role of Bregs.
Recently, studies have focused on counter-regulation of ex-
cessive immune responses. Several mechanisms have been 
suggested to mediate prevention of excessive suppression of 
tolerant responses to allergen by Br1 and Br3 cells in non-IgE-
mediated food allergy related to atopic dermatitis. 1) TGF-β 
produced by Br3 cells, which proliferate simultaneously with 
Br1 upon allergen stimulation, can induce apoptosis of regula-
tory B cells, including Br1 and Br3 cells. 2) Activation-induced 
apoptosis of B cells may also be an important negative regula-
tory mechanism.
72 3) Recently, IL-10 produced by Br1 cells was 
suggested as a counter-regulatory mechanism through the IL-
10/IL-27/IL-21 pathway.
73 However, proliferation with activa-
tion and apoptosis seem to conflict. Indeed, the IL-21 pathway 
induces proliferation of B cells simultaneously with apoptosis.
74 
4) Br1-induced Treg
19 suppress Br1, as described below.
75 Thus, 
Tregs may act as a counter-regulatory mechanism for Br1 re-
sponses.
Reciprocal roles of regulatory T and B cells
TGF-β, produced by either Th3 or Br3 cells, is critical for the 
function of CD4
+CD25
+Foxp3
+ regulatory T cells.
74 These cells 
Fig. 4. Reconstruction of Br1 and Br3 cell counter-regulatory mechanisms dur-
ing induction of tolerance to allergen stimulation. IL-10 produced by Br1 cells 
mediates counter-regulatory effects through the IL-10/IL-27/IL-21 pathway. 
TGF-β produced by Br3 cells also induced apoptosis of both Br1 and Br3 cells. 
Moreover, activation-mediated apoptosis plays a role in counter-regulation of 
immune responses.Noh et al.
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play a dominant role in the maintenance of immune tolerance, 
and also modulate immune reactions by secreting immuno-
modulatory cytokines, particularly TGF-β.
71,74 IL-10, produced 
by Tr1 and Br1 cells, drives the generation of Tr1 cells, which 
act to suppress antigen-specific immune responses and active-
ly down-regulate pathological immune responses.
76 IL-10 pro-
duced by Br1 cells may induce Tr1 cells, and also acts as an au-
tocrine growth factor for CD5
+ B cells, including Br1 and Br3 
cells. Treg cells suppress B1 cells,
75 while Br1 cells induce Treg 
cells in CD192/2 NZB/W mice.
19 TGF-β, produced by Br3, Th3 
and Treg cells, plays an important role in the development and 
function of CD4
+CD25
+Foxp3
+ regulatory T cells.
74 However, 
TGF-β induces apoptosis of B cells, including Br1 and Br3 cells. 
Thus, the reciprocal activities of Br1, Br3, Tr1, Th3, and Treg 
cells are known (Fig. 5) and their immunological roles should 
be investigated further.
Different immunological roles of Br1 and Treg cells
Br1 cells have different regulatory functions than Tregs, be-
cause they function at different time points during the initiation 
and progression of autoimmune diseases.
75 Br1 cells expand 
rapidly during experimental autoimmune encephalomyelitis 
(EAE) initiation and quickly inhibit disease severity, while De-
nileukin diftitox-induced Treg depletion had no effect on dis-
ease initiation, but exacerbated late-phase disease. Br1 cells 
predominantly reduced disease severity during EAE initiation 
through production of IL-10, whereas Tregs reciprocally inhib-
ited late stage EAE immunopathogenesis. In this context, Br1 
may be involved in the initiation of pathological responses and 
Tregs in their maintenance or progression.
Non-IgE-mediated food allergy is caused by allergen-specific 
Th2 cellular immune reactions. Specifically, induction of aller-
gen tolerance involves cell-mediated responses, including Br1 
and/or Br3 cells.
38,40 The roles of Br1 and Treg in non-IgE medi-
ated food allergy are expected to be similar to those in autoim-
mune disease (Fig. 6). Br1 cells play a role in early, and Tregs in 
later, phases of persistent allergic reactions. Autoantigen is con-
tinuously present, while the immune system is exposed to food 
antigen only intermittently and so prolonged persistent clinical 
allergic reactions are rare. Thus, Br1, rather than Treg, responses 
may be expected in food allergies. As expected, there has been 
no report of this change in the role of Tregs in food allergy de-
spite knowledge of Br1 and Br3 responses.
CONCLUDING REMARKS
Recently, there have been significant advances in understand-
ing the development, regulation, and roles of IL-10-producing 
regulatory B cells (Br1 or B10) as well as other regulatory B cell 
subsets, including TGF-β-producing Br3 and Foxp3-expressing 
Bregs. While most studies have focused primarily on autoim-
mune disease, regulatory B cells are also clinically and immu-
nologically significant in allergic diseases. Although there has 
been intensive investigation of Br1 cells, TGF-β-producing reg-
ulatory B cells (Br3) may also be involved in immune tolerance 
of non-IgE mediated food allergy related to atopic dermatitis. 
Currently, cytokine and cellular networks are investigated 
through assessing (i) their effects on regulatory B cells, (ii) re-
ciprocal effects between regulatory B and T cells, and (iii) the 
proper role of regulatory T and B cells. Moreover, Foxp3
+ regu-
latory B cells (Breg) appear to be compatible with Foxp3
+ regu-
latory T cells (Treg). The functional structure of regulatory B 
cells is similar to that of regulatory T cells. Additionally, both 
regulatory T and B cells seem to negatively regulate allergic dis-
eases including contact dermatitis, asthma, anaphylaxis and 
Fig. 5. Reciprocal roles of regulatory B and T cells. IL-10 from Br1 and Tr1 cells 
induces Tr1 and Treg cells. TGF-β produced by Br3 and Th3 cells induces Treg 
cells, which then act to suppress Br1 cells.
Fig. 6. Regulatory roles of regulatory B and T cells. Regulatory T and B cells 
function at different time points during initiation and progression of autoim-
mune diseases. Br1 and Br3 cells are decisive for tolerance induction in non-
IgE-mediated food allergy related to atopic dermatitis. In contrast, there has 
been no report of the role of Tregs in the development of allergy or tolerance. 
The roles of regulatory T and B cells in non-IgE-mediated food allergy related to 
atopic dermatitis may thus be similar to those in autoimmune disease.
Initiation of immune responses
Suppression of autoimmune 
disease development
Tolerance reaction to 
allergy provocation
Suppression of autoimmune 
disease progression
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Regulatory cell
In autoimmune disease
In non-lgE-mediated food allegy
Br1 Treg
Late phase
of prolonged immune responses Regulatory B Cells in Allergy
Allergy Asthma Immunol Res. 2011 July;3(3):168-177.  doi: 10.4168/aair.2011.3.3.168
AAIR 
175 http://e-aair.org
non-IgE-mediated food allergy related to atopic dermatitis. Fi-
nally, new regulatory B cell types are being discovered and so a 
systemic nomenclature is increasingly necessary.
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